SCHEMBL16281178

SCHEMBL16281178

COC(C)(C)C[C@@H](CO)N(C)C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22433099 0.78
SCHEMBL16281180 0.77 ALDH1A1 (0.35) ALDH1A1TSHRTDP1
SCHEMBL824974 0.71
SCHEMBL19822023 0.70 ALDH1A1 (0.32) ALDH1A1TSHRTDP1
SCHEMBL3217513 0.69 LMNA (0.40) ALDH1A1TSHRTDP1
SCHEMBL12632074 0.69 TSHR (0.39) ALDH1A1TSHRTDP1
SCHEMBL13832509 0.69
SCHEMBL23179734 0.68 MAPK1 (0.44)
SCHEMBL27271766 0.67 ALDH1A1 (0.38) ALDH1A1TSHRTDP1
SCHEMBL21000571 0.65 ALDH1A1 (0.37) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906853-B2 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection ENANTA PHARMACEUTICALS, INC. (US) 2014-12-09 US disclosed